These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

339 related items for PubMed ID: 25697229

  • 1. Influence of de novo donor-specific antibody on early renal allograft function recovery.
    Zheng J, Xue W, Jing X, Hou J, Tian X, Tian P, Ding X, Pan X, Yan H, Feng X, Xiang H, Li Y, Ding C.
    Ren Fail; 2015 Apr; 37(3):462-8. PubMed ID: 25697229
    [Abstract] [Full Text] [Related]

  • 2. Early Intervention in Living Kidney Transplantation Based on Dynamic Monitoring of Donor Specific Antibodies.
    Chen Y, Li LY, Lou XY, Wang H, Zhang L, Zhu YH.
    Clin Transpl; 2014 Apr; ():205-8. PubMed ID: 26281146
    [Abstract] [Full Text] [Related]

  • 3. Incidence and impact of de novo donor-specific alloantibody in primary renal allografts.
    Everly MJ, Rebellato LM, Haisch CE, Ozawa M, Parker K, Briley KP, Catrou PG, Bolin P, Kendrick WT, Kendrick SA, Harland RC, Terasaki PI.
    Transplantation; 2013 Feb 15; 95(3):410-7. PubMed ID: 23380861
    [Abstract] [Full Text] [Related]

  • 4. Posttransplant soluble B-cell activating factor kinetics in pediatric recipients of first kidney allograft.
    Comoli P, Quartuccio G, Cioni M, Parodi A, Nocera A, Basso S, Fontana I, Magnasco A, Sioli V, Guido I, Klersy C, Zecca M, Cardillo M, Ghiggeri GM, Ginevri F.
    Transplantation; 2015 Jan 15; 99(1):243-9. PubMed ID: 25033258
    [Abstract] [Full Text] [Related]

  • 5. De novo donor specific antibodies and patient outcomes in renal transplantation.
    DeVos JM, Patel SJ, Burns KM, Dilioglou S, Gaber LW, Knight RJ, Gaber AO, Land GA.
    Clin Transpl; 2011 Jan 15; ():351-8. PubMed ID: 22755430
    [Abstract] [Full Text] [Related]

  • 6. Clinical and anti-HLA antibody profile of nine renal transplant recipients with failed grafts: donor-specific and non-donor-specific antibody development.
    Rebellato LM, Ozawa M, Verbanac KM, Catrou P, Haisch CE, Terasaki PI.
    Clin Transpl; 2006 Jan 15; ():241-53. PubMed ID: 18365382
    [Abstract] [Full Text] [Related]

  • 7. Clinical significance of post kidney transplant de novo DSA in otherwise stable grafts.
    Cooper JE, Gralla J, Chan L, Wiseman AC.
    Clin Transpl; 2011 Jan 15; ():359-64. PubMed ID: 22755431
    [Abstract] [Full Text] [Related]

  • 8. Early De Novo Donor Specific Antibody Involvement in Delayed Graft Function After Kidney Transplantation: A Report of 2 Cases.
    Zhu L, Chen G, Zhang W, Guo H, Lin Z, Du D, Chen S, Shi H, Liu S, Chen Z.
    Clin Transpl; 2014 Jan 15; ():231-4. PubMed ID: 26281150
    [Abstract] [Full Text] [Related]

  • 9. Preformed donor-specific antibodies and risk of antibody-mediated rejection in repeat renal transplantation.
    Tsapepas DS, Vasilescu R, Tanriover B, Coppleson Y, Rekhtman Y, Hardy MA, Dube G, Crew RJ, Ratner LE, Cohen DJ, Mohan S.
    Transplantation; 2014 Mar 27; 97(6):642-7. PubMed ID: 24637863
    [Abstract] [Full Text] [Related]

  • 10. Donor-specific HLA antibodies in chronic renal allograft rejection: a prospective trial with a four-year follow-up.
    Lachmann N, Terasaki PI, Schönemann C.
    Clin Transpl; 2006 Mar 27; ():171-99. PubMed ID: 18365377
    [Abstract] [Full Text] [Related]

  • 11. The Utility of Donor-specific Antibody Monitoring and the Role of Kidney Biopsy in Simultaneous Liver and Kidney Recipients With De Novo Donor-specific Antibodies.
    Parajuli S, Aziz F, Blazel J, Muth BL, Garg N, Mohamed M, Rice J, Mezrich JD, Hidalgo LG, Mandelbrot D.
    Transplantation; 2021 Jul 01; 105(7):1548-1555. PubMed ID: 32732618
    [Abstract] [Full Text] [Related]

  • 12. A report of the epidemiology of de novo donor-specific anti-HLA antibodies (DSA) in "low-risk" renal transplant recipients.
    Rebellato LM, Everly MJ, Haisch CE, Ozawa M, Briley KP, Parker K, Catrou PG, Bolin P, Kendrick WT, Kendrick SA, Harland RC.
    Clin Transpl; 2011 Jul 01; ():337-40. PubMed ID: 22755428
    [Abstract] [Full Text] [Related]

  • 13. Impact of HLA antibodies on graft survival in long-term renal recipients with functional grafts.
    Zeng Y, Liu Z, Liu Y, Fan Y, Guo Y, Qiu J.
    Urol Int; 2014 Jul 01; 92(3):328-33. PubMed ID: 24480999
    [Abstract] [Full Text] [Related]

  • 14. Poor graft outcome in recipients with de novo donor-specific anti-HLA antibodies after living related kidney transplantation.
    Li X, Ishida H, Yamaguchi Y, Tanabe K.
    Transpl Int; 2008 Dec 01; 21(12):1145-52. PubMed ID: 18803618
    [Abstract] [Full Text] [Related]

  • 15. Targeted monitoring of donor-specific HLA antibodies following renal transplantation.
    Almeshari K, Pall A, Chaballout A, Elgamal H, Almana H, Alzayer F, Abaalkhail N, Altalhi M.
    Clin Transpl; 2011 Dec 01; ():395-400. PubMed ID: 22755437
    [Abstract] [Full Text] [Related]

  • 16. The impact of de novo donor-specific anti-human leukocyte antigen antibodies on 5-year renal transplant outcome.
    Banasik M, Boratyńska M, Kościelska-Kasprzak K, Mazanowska O, Krajewska M, Zabińska M, Bartoszek D, Myszka M, Nowakowska B, Dawiskiba T, Lepiesza A, Chudoba P, Klinger M.
    Transplant Proc; 2013 May 01; 45(4):1449-52. PubMed ID: 23726594
    [Abstract] [Full Text] [Related]

  • 17. Analysis of predictive and preventive factors for de novo DSA in kidney transplant recipients.
    Hirai T, Furusawa M, Omoto K, Ishida H, Tanabe K.
    Transplantation; 2014 Aug 27; 98(4):443-50. PubMed ID: 24717219
    [Abstract] [Full Text] [Related]

  • 18. Pre-transplant low level HLA antibody shows a composite poor outcome in long-term outcome of renal transplant recipients.
    Tian J, Li D, Alberghini TV, Rewinski M, Guo N, Bow LM.
    Ren Fail; 2015 Mar 27; 37(2):198-202. PubMed ID: 25565259
    [Abstract] [Full Text] [Related]

  • 19. Prospective Monitoring of Donor-specific Anti-HLA Antibodies After Intestine/Multivisceral Transplantation: Significance of De Novo Antibodies.
    Kubal C, Mangus R, Saxena R, Lobashevsky A, Higgins N, Fridell J, Tector AJ.
    Transplantation; 2015 Aug 27; 99(8):e49-56. PubMed ID: 25769071
    [Abstract] [Full Text] [Related]

  • 20. Donor-Recipient Matching Based on Predicted Indirectly Recognizable HLA Epitopes Independently Predicts the Incidence of De Novo Donor-Specific HLA Antibodies Following Renal Transplantation.
    Lachmann N, Niemann M, Reinke P, Budde K, Schmidt D, Halleck F, Pruß A, Schönemann C, Spierings E, Staeck O.
    Am J Transplant; 2017 Dec 27; 17(12):3076-3086. PubMed ID: 28613392
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.